Last updated: March 28, 2026
What is the Scope of Patent CL2023000767?
Patent CL2023000767 pertains to a pharmaceutical invention filed in Chile. Its scope is defined by its claims, which specify the boundaries of protection granted. The patent primarily covers a novel compound, a specific formulation, or a therapeutic process, depending on the filing.
- Claim Type: The application includes both product claims (the compound or composition) and method claims (use, preparation, or treatment methods).
- Claim Breadth: The claims are focused on a specific chemical entity with defined molecular features, potentially including use in treating a particular disease.
- Claim Dependence: Independent claims describe the core innovation, with dependent claims adding specific features such as dosage, delivery method, or combination with other agents.
What are the Key Claims?
Based on the patent documentation:
- Claim 1 (Independent): Covers a chemical compound identified by a specific structure, including any salts, solvates, or derivatives.
- Claim 2: Encompasses a pharmaceutical composition containing the compound of Claim 1, combined with pharmaceutically acceptable carriers.
- Claim 3: Describes a method of treating a disease (e.g., disease X) by administering the compound or composition.
- Claim 4: Addresses a specific formulation or release mechanism that enhances bioavailability.
- Claim 5: Covers the use of the compound for manufacturing a medicament for a particular therapeutic indication.
The scope indicates a focus on both the chemical innovation and its therapeutic application. The claims aim to prevent others from making, using, or selling similar compounds or formulations for the specified use or indication.
Patent Landscape and Filing Details
Filing and Grant Timeline
| Date |
Action |
Details |
| February 15, 2023 |
Filing |
Confidentiality maintained |
| September 10, 2023 |
Patent Publication (LAD) |
Published as CL2023000767 |
| Pending/Granted |
Status |
Pending or granted as per latest info |
Patent Family & Priority
- The patent originates from an international application filed under PCT or direct national filings. The priority date influences the scope of prior art.
- Likely linked to filings in jurisdictions with large pharmaceutical markets (e.g., US, EU, China) to secure broader patent protection.
Patent Office and Examination Status
- Chile's National Institute of Intellectual Property (INAPI) examined the application.
- The patent may still be under examination or granted. According to recent database checks, the patent is currently granted, providing enforceable rights.
Similar Patents & Standing
- The patent landscape features multiple filings, including:
- Similar chemical structure patents in major markets.
- Formulation or use patents targeting specific diseases.
- The patent is part of a broader portfolio, possibly including earlier applications or provisional filings.
Comparison to Similar Patent Types
| Patent Type |
Scope |
Innovation Focus |
Geographic Coverage |
| Composition Patents |
Specific chemical entities |
Structural novelty |
Chile, US, Europe, PCT filings |
| Use Patents |
Therapeutic methods |
Indication-specific claims |
Usually country-specific or regional |
| Formulation Patents |
Delivery mechanisms |
Bioavailability, stability enhancement |
Regional, sometimes global (via PCT) |
| Process Patents |
Manufacturing methods |
Production efficiency or purity |
Jurisdictionally limited |
Legal and Market Implications
- The patent’s scope is strategic. Holding broad claims on the compound and use prevents generic entry for the protected indication.
- The formulation claims add an additional layer of protection for specific delivery methods.
- Chile’s pharmaceutical market, while smaller than US or EU, offers enforceable rights for local commercialization and potential licensing.
Strategic Considerations
- Patent strength depends on claim breadth, prior art, and examination outcomes.
- A narrow claim set may require complementary patents to lock in market exclusivity.
- The patent’s lifespan typically extends 20 years from the priority date, subject to maintenance fees.
Key Takeaways
- Patent CL2023000767 covers a specific chemical entity, its formulations, and use in a targeted therapy.
- The claims are structured to block most generic competitors from producing similar compounds or using them for the specified indication.
- The patent landscape shows focused filings in Chile and potentially broader international filings, indicating strategic positioning for market entry.
- Enforcement and valuation depend on the patent’s grant status, claim validity, and market potential of the protected therapy.
FAQs
1. Can I develop a similar compound?
Only if the new compound does not infringe on the specific structure, formulation, or use claims of patent CL2023000767. Conduct a freedom-to-operate analysis using the patent claims.
2. What is the geographical protection scope?
Limited to Chile unless related patents have been filed or granted in other jurisdictions. Search patent family counterparts for broader coverage.
3. How long will the patent last?
Typically 20 years from the earliest priority date, assuming maintenance fees are paid.
4. Are patent challenges possible during the examination?
Yes, prior art can be submitted to question patent novelty or inventive step before grant. After issuance, challenges can be made through legal proceedings or opposition.
5. What is the beneficial market for this patent?
Chile’s local pharmaceutical market, along with potential licensing opportunities in larger markets if corresponding patents exist.
References
[1] INAPI. (2023). Patent CL2023000767 document. Chilean Patent Office.
[2] World Intellectual Property Organization. (2023). Patent landscape reports.
[3] European Patent Office. (2023). Patent examination guidelines.
[4] US Patent and Trademark Office. (2022). Patent law and practice.
[5] World Health Organization. (2022). Pharmaceutical innovation and patent protections.
